Lazard Asset Management LLC Precision Biosciences Inc Transaction History

Lazard Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.7 - $1.41 $882 - $1,776	1,260 Added 19.78%	7,629 $5,000
Q4 2022 Feb 14, 2023	BUY	$0.97 - $45.0 $6,177 - $286,605	6,369 New	6,369 $7,000
Q1 2022 May 13, 2022	SELL	$2.96 - $7.76 $3,460 - $9,071	-1,169 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$7.4 - $11.66 $55,093 - $86,808	-7,445 Reduced 86.43%	1,169 $8,000
Q3 2021 Nov 15, 2021	BUY	$9.18 - $14.15 $15,881 - $24,479	1,730 Added 25.13%	8,614 $99,000
Q2 2021 Aug 12, 2021	BUY	$8.07 - $12.52 $55,553 - $86,187	6,884 New	6,884 $86,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $539M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.